Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine

NCT02489929 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Myeloid Leukemia
Myelodysplastic Syndromes

Interventions

OTHER: blood samples
DRUG: azacytidine

Sponsor

Assistance Publique Hopitaux De Marseille